Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis
© 2024. The Author(s)..
Valosin-containing protein (VCP)/p97, an AAA+ ATPase critical for maintaining proteostasis, emerges as a promising target for cancer therapy. This study reveals that targeting VCP selectively eliminates breast cancer cells while sparing non-transformed cells by inducing paraptosis, a non-apoptotic cell death mechanism characterized by endoplasmic reticulum and mitochondria dilation. Intriguingly, oncogenic HRas sensitizes non-transformed cells to VCP inhibition-mediated paraptosis. The susceptibility of cancer cells to VCP inhibition is attributed to the non-attenuation and recovery of protein synthesis under proteotoxic stress. Mechanistically, mTORC2/Akt activation and eIF3d-dependent translation contribute to translational rebound and amplification of proteotoxic stress. Furthermore, the ATF4/DDIT4 axis augments VCP inhibition-mediated paraptosis by activating Akt. Given that hyperactive Akt counteracts chemotherapeutic-induced apoptosis, VCP inhibition presents a promising therapeutic avenue to exploit Akt-associated vulnerabilities in cancer cells by triggering paraptosis while safeguarding normal cells.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Cell death & disease - 15(2024), 1 vom: 13. Jan., Seite 48 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lee, Dong Min [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adenosine Triphosphatases |
|---|
| Anmerkungen: |
Date Completed 15.01.2024 Date Revised 25.01.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41419-024-06434-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367094703 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367094703 | ||
| 003 | DE-627 | ||
| 005 | 20240126232131.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41419-024-06434-x |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1271.xml |
| 035 | |a (DE-627)NLM367094703 | ||
| 035 | |a (NLM)38218922 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lee, Dong Min |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.01.2024 | ||
| 500 | |a Date Revised 25.01.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a Valosin-containing protein (VCP)/p97, an AAA+ ATPase critical for maintaining proteostasis, emerges as a promising target for cancer therapy. This study reveals that targeting VCP selectively eliminates breast cancer cells while sparing non-transformed cells by inducing paraptosis, a non-apoptotic cell death mechanism characterized by endoplasmic reticulum and mitochondria dilation. Intriguingly, oncogenic HRas sensitizes non-transformed cells to VCP inhibition-mediated paraptosis. The susceptibility of cancer cells to VCP inhibition is attributed to the non-attenuation and recovery of protein synthesis under proteotoxic stress. Mechanistically, mTORC2/Akt activation and eIF3d-dependent translation contribute to translational rebound and amplification of proteotoxic stress. Furthermore, the ATF4/DDIT4 axis augments VCP inhibition-mediated paraptosis by activating Akt. Given that hyperactive Akt counteracts chemotherapeutic-induced apoptosis, VCP inhibition presents a promising therapeutic avenue to exploit Akt-associated vulnerabilities in cancer cells by triggering paraptosis while safeguarding normal cells | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Valosin Containing Protein |2 NLM | |
| 650 | 7 | |a EC 3.6.4.6 |2 NLM | |
| 650 | 7 | |a Proto-Oncogene Proteins c-akt |2 NLM | |
| 650 | 7 | |a EC 2.7.11.1 |2 NLM | |
| 650 | 7 | |a Adenosine Triphosphatases |2 NLM | |
| 650 | 7 | |a EC 3.6.1.- |2 NLM | |
| 650 | 7 | |a Cell Cycle Proteins |2 NLM | |
| 700 | 1 | |a Kim, In Young |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Hong Jae |e verfasserin |4 aut | |
| 700 | 1 | |a Seo, Min Ji |e verfasserin |4 aut | |
| 700 | 1 | |a Cho, Mi-Young |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Hae In |e verfasserin |4 aut | |
| 700 | 1 | |a Yoon, Gyesoon |e verfasserin |4 aut | |
| 700 | 1 | |a Ji, Jae-Hoon |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Seok Soon |e verfasserin |4 aut | |
| 700 | 1 | |a Jeong, Seong-Yun |e verfasserin |4 aut | |
| 700 | 1 | |a Choi, Eun Kyung |e verfasserin |4 aut | |
| 700 | 1 | |a Choi, Yong Hyeon |e verfasserin |4 aut | |
| 700 | 1 | |a Yun, Chae-Ok |e verfasserin |4 aut | |
| 700 | 1 | |a Yeo, Mirae |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Eunhee |e verfasserin |4 aut | |
| 700 | 1 | |a Choi, Kyeong Sook |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell death & disease |d 2010 |g 15(2024), 1 vom: 13. Jan., Seite 48 |w (DE-627)NLM202030881 |x 2041-4889 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |g number:1 |g day:13 |g month:01 |g pages:48 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41419-024-06434-x |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2024 |e 1 |b 13 |c 01 |h 48 | ||